MedPath

Risk of Revision Following Knee Arthroplasty in Bariatric Surgery Patients

Active, not recruiting
Conditions
Prosthesis Failure
Prosthesis Survival
Bariatric Surgery Candidate
Prosthesis-Related Infections
Arthritis Knee
Interventions
Other: BAS
Other: Non-BAS
Registration Number
NCT06433700
Lead Sponsor
Bispebjerg Hospital
Brief Summary

Previous studies have investigated the outcomes of Knee Arthroplasty (KA) following Bariatric Surgery (BAS), but with substantial limitations as not stratifying for Body Mass Index (BMI) at time of KA or not addressing the type of BAS (gastric bypass, banding or sleeve). Since BMI varies greatly in patients with previous BAS, it is likely that BMI affects outcomes after KA in BAS-operated patients.

The investigators believe that stratifying for BMI would explain the contradictions with the previous research in this patient group when it comes to the risk of revision after KA.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
90000
Inclusion Criteria
  • Primary knee arthroplasty due to osteoarthritis
Exclusion Criteria
  • Primary knee arthroplasty due to traumatic osteoarthritis.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
BAS groupBASPatients who received bariatric surgery prior to their knee arthroplasty
Non-BAS groupNon-BASPatients who did not receive bariatric surgery prior to their knee arthroplasty
Primary Outcome Measures
NameTimeMethod
Hazard rate of Revision due to any causewithin 90 days and within 2 years

Revision surgery is defined as surgery with debridement and/or exchange of at least one component

Hazard rate of Revision due to infectionwithin 90 days and within 2 years

Our definition of infection is adapted from the European Bone and Joint Infection Society (EBJIS) criteria as at least one of the following A. An indication of deep infection is reported to the Danish knee arthroplasty register (DKR) by the surgeon on revision surgery B. At least 2 deep-tissue samples of phenotypically indistinguishable bacteria isolated from at least 3 deep-tissue samples C. One or more positive intraoperative samples from a closed fluid aspirate AND a biopsy (fluid AND tissue) of phenotypically indistinguishable bacteria isolated.

Secondary Outcome Measures
NameTimeMethod
Mortality2 years postoperatively

Mortality registered in the Danish Civil Registration System (DCRS) by date

Hazard rate of Knee related antibiotic use within 30- and 90-days following KAwithin 30- and 90-days following KA

the use of one of the following oral antibiotics: dicloxacillin, flucloxacillin, phenoxymethylpenicillin, amoxicillin, oral ciprofloxacin, roxithromycin, linezolid, cefuroxime and cefalexin

Hazard rate of Antibiotic use due to other causeswithin 30- and 90-days following KA

the use of one of oral antibiotics other than those that were mentioned in outcome 3.

Trial Locations

Locations (1)

Orthopaedic department, Bispebjerg Hospital

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath